Molecular profile
Molecular profile
- Molecule class
- Endogenous peptide
- Origin
- Synthetic analogue
- Primary target system
- T-Zell-, dendritische Zell- und Toll-like-Rezeptor-assoziierte Immunantworten
- Development stage
- Authorised active substance
Synthetisch hergestellte Form eines Thymuspeptids.
Mechanism and signalling
Mechanism and signalling
Research examines innate and adaptive immune responses, including dendritic cells, T-cell maturation and pattern-recognition receptors.
Scientific classification
Scientific classification
This profile maps Thymosin alpha-1 to the research areas immune. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Innate immunity, epithelial barriers and antimicrobial peptide functions.
Evidence base
Clinical data
Numerous clinical studies exist across different conditions, but designs, indications and outcomes are heterogeneous. No general therapeutic conclusion can be drawn.
Regulatory status
Status varies by region
Regulatory status differs by country, product form and intended use. Authorisation in one jurisdiction does not transfer to Germany or the EU.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries